These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Novel INF2 mutation p. L77P in a family with glomerulopathy and Charcot-Marie-Tooth neuropathy. Rodriguez PQ, Lohkamp B, Celsi G, Mache CJ, Auer-Grumbach M, Wernerson A, Hamajima N, Tryggvason K, Patrakka J. Pediatr Nephrol; 2013 Feb; 28(2):339-43. PubMed ID: 22961558 [Abstract] [Full Text] [Related]
5. INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy. Boyer O, Nevo F, Plaisier E, Funalot B, Gribouval O, Benoit G, Huynh Cong E, Arrondel C, Tête MJ, Montjean R, Richard L, Karras A, Pouteil-Noble C, Balafrej L, Bonnardeaux A, Canaud G, Charasse C, Dantal J, Deschenes G, Deteix P, Dubourg O, Petiot P, Pouthier D, Leguern E, Guiochon-Mantel A, Broutin I, Gubler MC, Saunier S, Ronco P, Vallat JM, Alonso MA, Antignac C, Mollet G. N Engl J Med; 2011 Dec 22; 365(25):2377-88. PubMed ID: 22187985 [Abstract] [Full Text] [Related]
8. Inverted formin 2 regulates actin dynamics by antagonizing Rho/diaphanous-related formin signaling. Sun H, Schlondorff J, Higgs HN, Pollak MR. J Am Soc Nephrol; 2013 May 22; 24(6):917-29. PubMed ID: 23620398 [Abstract] [Full Text] [Related]
9. INF2 mutations associated with dominant inherited intermediate Charcot-Marie-Tooth neuropathy with focal segmental glomerulosclerosis in two Chinese patients. Jin S, Wang W, Wang R, Lv H, Zhang W, Wang Z, Jiao J, Yuan Y. Clin Neuropathol; 2015 May 22; 34(5):275-81. PubMed ID: 25943269 [Abstract] [Full Text] [Related]
13. INF2 mutations in patients with a broad phenotypic spectrum of Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis. Park JH, Kwon HM, Nam DE, Kim HJ, Nam SH, Kim SB, Choi BO, Chung KW. J Peripher Nerv Syst; 2023 Mar 22; 28(1):108-118. PubMed ID: 36637069 [Abstract] [Full Text] [Related]
14. A Deregulated Stress Response Underlies Distinct INF2-Associated Disease Profiles. Bayraktar S, Nehrig J, Menis E, Karli K, Janning A, Struk T, Halbritter J, Michgehl U, Krahn MP, Schuberth CE, Pavenstädt H, Wedlich-Söldner R. J Am Soc Nephrol; 2020 Jun 22; 31(6):1296-1313. PubMed ID: 32444357 [Abstract] [Full Text] [Related]
15. Inverted formin 2-related Charcot-Marie-Tooth disease: extension of the mutational spectrum and pathological findings in Schwann cells and axons. Roos A, Weis J, Korinthenberg R, Fehrenbach H, Häusler M, Züchner S, Mache C, Hubmann H, Auer-Grumbach M, Senderek J. J Peripher Nerv Syst; 2015 Mar 22; 20(1):52-9. PubMed ID: 25676889 [Abstract] [Full Text] [Related]
17. The formin INF2 in disease: progress from 10 years of research. Labat-de-Hoz L, Alonso MA. Cell Mol Life Sci; 2020 Nov 22; 77(22):4581-4600. PubMed ID: 32451589 [Abstract] [Full Text] [Related]
18. The disease-associated formin INF2/EXC-6 organizes lumen and cell outgrowth during tubulogenesis by regulating F-actin and microtubule cytoskeletons. Shaye DD, Greenwald I. Dev Cell; 2015 Mar 23; 32(6):743-55. PubMed ID: 25771894 [Abstract] [Full Text] [Related]
19. A cryptic splicing mutation in the INF2 gene causing Charcot-Marie-Tooth disease with minimal glomerular dysfunction. Echaniz-Laguna A, Latour P. J Peripher Nerv Syst; 2019 Mar 23; 24(1):120-124. PubMed ID: 30680856 [Abstract] [Full Text] [Related]
20. Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis. Boyer O, Benoit G, Gribouval O, Nevo F, Tête MJ, Dantal J, Gilbert-Dussardier B, Touchard G, Karras A, Presne C, Grunfeld JP, Legendre C, Joly D, Rieu P, Mohsin N, Hannedouche T, Moal V, Gubler MC, Broutin I, Mollet G, Antignac C. J Am Soc Nephrol; 2011 Feb 23; 22(2):239-45. PubMed ID: 21258034 [Abstract] [Full Text] [Related] Page: [Next] [New Search]